Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.

Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.

Item
http://www.wikidata.org/entity/Q37052393
Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamineNeuroimmune basis of methamphetamine toxicityFlagellin as carrier and adjuvant in cocaine vaccine development.Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study.Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning.Opioid Use Disorder: A Desperate Need for Novel Treatments.Investigations into the efficacy of multi-component cocaine vaccines.Telomere length in psychiatric disorders: Is it more than an ageing marker?Protein Kinase Cδ Gene Depletion Protects Against Methamphetamine-Induced Impairments in Recognition Memory and ERK1/2 Signaling via Upregulation of Glutathione Peroxidase-1 Gene.Efficient Syntheses of Cocaine Vaccines and Their in Vivo Evaluation.Association of leukocytosis with amphetamine and cocaine use
P2860

Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.

Item
http://www.wikidata.org/entity/Q37052393
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.
@en
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.
@nl
type
label
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.
@en
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.
@nl
prefLabel
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.
@en
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.
@en
P2093
P2860
P304
P31
P356
10.1016/J.PHARMTHERA.2013.04.011
P433
P478
P577
P698
P921
P932